miR-29b is an indicator of prognosis in breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-29b is an indicator of prognosis in breast cancer patients

Published:2015-05-12 Issue:4 Volume:3 Page:919-923
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:en
Short-container-title:

Author:

SHINDEN YOSHIAKI,IGUCHI TOMOHIRO,AKIYOSHI SAYURI,UEO HIROKI,UEDA MASAMI,HIRATA HIDENARI,SAKIMURA SHOTARO,UCHI RYUTARO,TAKANO YUKI,EGUCHI HIDETOSHI,SUGIMACHI KEISHI,KIJIMA YUKO,NATSUGOE SHOJI,MIMORI KOSHI

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. POU2F1 inhibits miR-29b1/a cluster-mediated suppression of PIK3R1 and PIK3R3 expression to regulate gastric cancer cell invasion and migration;Chinese Medical Journal;2024-08-26

2. MicroRNA signature of stromal-epithelial interactions in prostate and breast cancers;Experimental Cell Research;2024-08

3. In‐silico and in‐vitro evidence suggest LINC01405 as a sponge for miR‐29b and miR‐497‐5p, and a potential regulator of Wnt, PI3K, and TGFB signaling pathways in breast carcinoma;Cancer Reports;2024-01-15

4. STEN ameliorates VEGF gene expression by improving XBP1/mRNA-21/mRNA-330 signalling pathways in cisplatin-induced uterus injury in rats;Journal of Drug Delivery Science and Technology;2023-09

5. Overview of the miR-29 family members' function in breast cancer;International Journal of Biological Macromolecules;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP